Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 1
Ce profil est validé par 1 label.

Company

Laserix SA

Laserix SA_logo
8
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

New Arthroscopic Method to Treat and Cure early Arthrosis for the veterinary market (ready) and the medical human market Be the leader in developing laser-based innovative solutions for arthrosis treatment.

Genève, Genève, Switzerland

Send a message

Anglais

Laserix SA

Anglais

Laserix was founded by Prof. Pierre Ravussin, physicist engineer from the Federal Institute of Technology of Lausanne (EPFL), and Key Opinion Leader (KOL) in the field of lasers, Dr. Gilbert Mouthon, Professor at the Ecole Nationale Vétérinaire de Maison Alfort (France) and Mr. Claude Daenzer (†).

Laserix SA is specialized in the development and manufacturing of lasers for veterinary and medical applications. Cartilex, for the treatment of osteoarthritis in horses and dogs then...

See more

Laserix was founded by Prof. Pierre Ravussin, physicist engineer from the Federal Institute of Technology of Lausanne (EPFL), and Key Opinion Leader (KOL) in the field of lasers, Dr. Gilbert Mouthon, Professor at the Ecole Nationale Vétérinaire de Maison Alfort (France) and Mr. Claude Daenzer (†).

Laserix SA is specialized in the development and manufacturing of lasers for veterinary and medical applications. Cartilex, for the treatment of osteoarthritis in horses and dogs then humans. Following preliminary testing at Ecole Nationale Vétérinaire d'Alfort and Institut of Pathology of Bern University, the use of Cartilex on racing horses with osteoarthritis have started in 2014, generating spectacular results.

The priority is Cartilex, the patented technique to cure early arthrotic articular.

 

Board of directors

  • Prof Pierre Ravussin, president (main shareholder)
  • Prof Gilbert Mouthon, veterinary issues
  • M. Celine Schmid, business development
  • M. Charles Ravussin, Information technologies.
  • M. Axel Schmid , EMEA Finance leader

 

Scientific advisory board

  • Pierre Ravussin Cartilex specialist
  • Prof Gilbert Mouthon, veterinary and biochimist Dr
  • Dr. med. Christophe Rateau, Responsible for the veterinary Cartilex transition to the human medical field.
  • Dr. med. Bruno Gerber, senior orthopedic surgeon at Lewisham univerasity hospital, London, Opinion leader.
  • Dr. vet. Theo Tschanz, Horse clinic Neugraben SA, Cartilex user expert.

 

Capital action CHF 665’375.-

  • 1

    Like

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
161 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1221 Members